BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19094843)

  • 1. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
    Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
    Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
    Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
    Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
    J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
    Ruggiero A; Maurizi P; Larocca LM; Arlotta A; Riccardi R
    Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature.
    Li Y; Li Z; Lin HL; Chen XH; Li B
    Pathol Res Pract; 2011 Jan; 207(1):55-9. PubMed ID: 20573459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
    Hamadani M; Magro CM; Porcu P
    Br J Haematol; 2008 Jan; 140(2):122. PubMed ID: 17991297
    [No Abstract]   [Full Text] [Related]  

  • 8. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
    Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M
    J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
    Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C
    Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a case report.
    Wang P; Wang Z; Kong Y; Xu A
    Int J Dermatol; 2009 Jan; 48(1):62-5. PubMed ID: 19126053
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma.
    Di Mario A; Garzia M; d'Alò F; Rumi C; Massini G; Bellesi S; Zini G
    Hematology; 2007 Apr; 12(2):155-7. PubMed ID: 17454197
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous CD4+/CD56+ hematodermic neoplasm.
    Zindanci I; Kavala M; Buyukbabani N; Kocaturk E; Koc M
    Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
    Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
    Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
    Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+/CD56+ hematodermic neoplasm: blastic NK cell lymphoma in a 6-year-old child: report of a case and review of literature.
    Eguaras AV; Lo RW; Veloso JD; Tan VG; Enriquez ML; Del Rosario ML
    J Pediatr Hematol Oncol; 2007 Nov; 29(11):766-9. PubMed ID: 17984695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
    Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
    J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
    Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
    Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.